Platelet Rich Plasma Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Type (Pure Platelet-rich Plasma, Leukocyte-rich Platelet-rich Plasma, Pure Platelet-rich Fibrin); Origin (Autologous platelet-rich plasma, Allogenic platelet-rich plasma, Homologus platelet-rich plasma); Application (Orthopedics, Cosmetic surgery and dermatology, Ophthalmic surgery, Neurosurgery, General surgery, Others)

Report Code: TIPRE00020948 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
Covid
MARKET INTRODUCTION

Platelet-rich plasma (PRP) therapy are injections of patient's own concentrated platelets that accelerate the healing process of injured tendons, ligaments, muscles and joints or any musculoskeletal problems. As this therapy consists of patients own cells, these injections are safe. These are widely used among athletes to fasten the process of healing.

MARKET DYNAMICS

The platelet rich plasma market is driving due to growing number of sport injuries and orthopedic diseases and increasing awareness for platelet-rich plasma (PRP) therapy. Moreover, growing application of PRP therapy in cosmetic surgery may create growth opportunities for the market.

MARKET SCOPE

The "Platelet rich plasma Market Analysis to 2027" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of platelet rich plasma market with detailed market segmentation by type, origin and application. The platelet rich plasma market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in platelet rich plasma market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The platelet rich plasma market is segmented on the basis of type, origin and application. Based on type, the market is segmented as pure platelet-rich plasma, leukocyte-rich platelet-rich plasma, pure platelet-rich fibrin. The origin segment is segmented into autologous platelet-rich plasma, allogenic platelet-rich plasma, and homologus platelet-rich plasma. On the basis of application, the market is segmented into orthopedics, cosmetic surgery and dermatology, ophthalmic surgery, neurosurgery, general surgery, and others.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the platelet rich plasma market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The platelet rich plasma market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting platelet rich plasma market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Platelet rich plasma market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the platelet rich plasma market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from platelet rich plasma market are anticipated to have lucrative growth opportunities in the future with the rising demand for platelet rich plasma in the global market. Below mentioned is the list of few companies engaged in the platelet rich plasma market.

The report also includes the profiles of key players in platelet rich plasma market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •   T-BIOTECHNOLOGY
  •   ARTHREX, INC.
  •   TERUMO BCT, INC
  •   EMCYTE CORPORATION
  •   DEPUY SYNTHES
  •   ZIMMER BIOMET
  •   STRYKER
  •   GLOFINN OY
  •   DR. PRP AMERICA
  •   CSL LIMITED

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Platelet Rich Plasma Market - By Type
1.3.2 Platelet Rich Plasma Market - By Origin
1.3.3 Platelet Rich Plasma Market - By Application
1.3.4 Platelet Rich Plasma Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. PLATELET RICH PLASMA MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. PLATELET RICH PLASMA MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. PLATELET RICH PLASMA MARKET - GLOBAL MARKET ANALYSIS
6.1. PLATELET RICH PLASMA - GLOBAL MARKET OVERVIEW
6.2. PLATELET RICH PLASMA - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. PLATELET RICH PLASMA MARKET - REVENUE AND FORECASTS TO 2028 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. PURE PLATELET-RICH PLASMA
7.3.1. Overview
7.3.2. Pure Platelet-rich Plasma Market Forecast and Analysis
7.4. LEUKOCYTE-RICH PLATELET-RICH PLASMA
7.4.1. Overview
7.4.2. Leukocyte-rich Platelet-rich Plasma Market Forecast and Analysis
7.5. PURE PLATELET-RICH FIBRIN
7.5.1. Overview
7.5.2. Pure Platelet-rich Fibrin Market Forecast and Analysis
8. PLATELET RICH PLASMA MARKET - REVENUE AND FORECASTS TO 2028 - ORIGIN
8.1. OVERVIEW
8.2. ORIGIN MARKET FORECASTS AND ANALYSIS
8.3. AUTOLOGOUS PLATELET-RICH PLASMA
8.3.1. Overview
8.3.2. Autologous platelet-rich plasma Market Forecast and Analysis
8.4. ALLOGENIC PLATELET-RICH PLASMA
8.4.1. Overview
8.4.2. Allogenic platelet-rich plasma Market Forecast and Analysis
8.5. HOMOLOGUS PLATELET-RICH PLASMA
8.5.1. Overview
8.5.2. Homologus platelet-rich plasma Market Forecast and Analysis
9. PLATELET RICH PLASMA MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
9.1. OVERVIEW
9.2. APPLICATION MARKET FORECASTS AND ANALYSIS
9.3. ORTHOPEDICS
9.3.1. Overview
9.3.2. Orthopedics Market Forecast and Analysis
9.4. COSMETIC SURGERY AND DERMATOLOGY
9.4.1. Overview
9.4.2. Cosmetic surgery and dermatology Market Forecast and Analysis
9.5. OPHTHALMIC SURGERY
9.5.1. Overview
9.5.2. Ophthalmic surgery Market Forecast and Analysis
9.6. NEUROSURGERY
9.6.1. Overview
9.6.2. Neurosurgery Market Forecast and Analysis
9.7. GENERAL SURGERY
9.7.1. Overview
9.7.2. General surgery Market Forecast and Analysis
9.8. OTHERS
9.8.1. Overview
9.8.2. Others Market Forecast and Analysis
10. PLATELET RICH PLASMA MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Platelet Rich Plasma Market Overview
10.1.2 North America Platelet Rich Plasma Market Forecasts and Analysis
10.1.3 North America Platelet Rich Plasma Market Forecasts and Analysis - By Type
10.1.4 North America Platelet Rich Plasma Market Forecasts and Analysis - By Origin
10.1.5 North America Platelet Rich Plasma Market Forecasts and Analysis - By Application
10.1.6 North America Platelet Rich Plasma Market Forecasts and Analysis - By Countries
10.1.6.1 United States Platelet Rich Plasma Market
10.1.6.1.1 United States Platelet Rich Plasma Market by Type
10.1.6.1.2 United States Platelet Rich Plasma Market by Origin
10.1.6.1.3 United States Platelet Rich Plasma Market by Application
10.1.6.2 Canada Platelet Rich Plasma Market
10.1.6.2.1 Canada Platelet Rich Plasma Market by Type
10.1.6.2.2 Canada Platelet Rich Plasma Market by Origin
10.1.6.2.3 Canada Platelet Rich Plasma Market by Application
10.1.6.3 Mexico Platelet Rich Plasma Market
10.1.6.3.1 Mexico Platelet Rich Plasma Market by Type
10.1.6.3.2 Mexico Platelet Rich Plasma Market by Origin
10.1.6.3.3 Mexico Platelet Rich Plasma Market by Application
10.2. EUROPE
10.2.1 Europe Platelet Rich Plasma Market Overview
10.2.2 Europe Platelet Rich Plasma Market Forecasts and Analysis
10.2.3 Europe Platelet Rich Plasma Market Forecasts and Analysis - By Type
10.2.4 Europe Platelet Rich Plasma Market Forecasts and Analysis - By Origin
10.2.5 Europe Platelet Rich Plasma Market Forecasts and Analysis - By Application
10.2.6 Europe Platelet Rich Plasma Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Platelet Rich Plasma Market
10.2.6.1.1 Germany Platelet Rich Plasma Market by Type
10.2.6.1.2 Germany Platelet Rich Plasma Market by Origin
10.2.6.1.3 Germany Platelet Rich Plasma Market by Application
10.2.6.2 France Platelet Rich Plasma Market
10.2.6.2.1 France Platelet Rich Plasma Market by Type
10.2.6.2.2 France Platelet Rich Plasma Market by Origin
10.2.6.2.3 France Platelet Rich Plasma Market by Application
10.2.6.3 Italy Platelet Rich Plasma Market
10.2.6.3.1 Italy Platelet Rich Plasma Market by Type
10.2.6.3.2 Italy Platelet Rich Plasma Market by Origin
10.2.6.3.3 Italy Platelet Rich Plasma Market by Application
10.2.6.4 Spain Platelet Rich Plasma Market
10.2.6.4.1 Spain Platelet Rich Plasma Market by Type
10.2.6.4.2 Spain Platelet Rich Plasma Market by Origin
10.2.6.4.3 Spain Platelet Rich Plasma Market by Application
10.2.6.5 United Kingdom Platelet Rich Plasma Market
10.2.6.5.1 United Kingdom Platelet Rich Plasma Market by Type
10.2.6.5.2 United Kingdom Platelet Rich Plasma Market by Origin
10.2.6.5.3 United Kingdom Platelet Rich Plasma Market by Application
10.2.6.6 Rest of Europe Platelet Rich Plasma Market
10.2.6.6.1 Rest of Europe Platelet Rich Plasma Market by Type
10.2.6.6.2 Rest of Europe Platelet Rich Plasma Market by Origin
10.2.6.6.3 Rest of Europe Platelet Rich Plasma Market by Application
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Platelet Rich Plasma Market Overview
10.3.2 Asia-Pacific Platelet Rich Plasma Market Forecasts and Analysis
10.3.3 Asia-Pacific Platelet Rich Plasma Market Forecasts and Analysis - By Type
10.3.4 Asia-Pacific Platelet Rich Plasma Market Forecasts and Analysis - By Origin
10.3.5 Asia-Pacific Platelet Rich Plasma Market Forecasts and Analysis - By Application
10.3.6 Asia-Pacific Platelet Rich Plasma Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Platelet Rich Plasma Market
10.3.6.1.1 Australia Platelet Rich Plasma Market by Type
10.3.6.1.2 Australia Platelet Rich Plasma Market by Origin
10.3.6.1.3 Australia Platelet Rich Plasma Market by Application
10.3.6.2 China Platelet Rich Plasma Market
10.3.6.2.1 China Platelet Rich Plasma Market by Type
10.3.6.2.2 China Platelet Rich Plasma Market by Origin
10.3.6.2.3 China Platelet Rich Plasma Market by Application
10.3.6.3 India Platelet Rich Plasma Market
10.3.6.3.1 India Platelet Rich Plasma Market by Type
10.3.6.3.2 India Platelet Rich Plasma Market by Origin
10.3.6.3.3 India Platelet Rich Plasma Market by Application
10.3.6.4 Japan Platelet Rich Plasma Market
10.3.6.4.1 Japan Platelet Rich Plasma Market by Type
10.3.6.4.2 Japan Platelet Rich Plasma Market by Origin
10.3.6.4.3 Japan Platelet Rich Plasma Market by Application
10.3.6.5 South Korea Platelet Rich Plasma Market
10.3.6.5.1 South Korea Platelet Rich Plasma Market by Type
10.3.6.5.2 South Korea Platelet Rich Plasma Market by Origin
10.3.6.5.3 South Korea Platelet Rich Plasma Market by Application
10.3.6.6 Rest of Asia-Pacific Platelet Rich Plasma Market
10.3.6.6.1 Rest of Asia-Pacific Platelet Rich Plasma Market by Type
10.3.6.6.2 Rest of Asia-Pacific Platelet Rich Plasma Market by Origin
10.3.6.6.3 Rest of Asia-Pacific Platelet Rich Plasma Market by Application
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Platelet Rich Plasma Market Overview
10.4.2 Middle East and Africa Platelet Rich Plasma Market Forecasts and Analysis
10.4.3 Middle East and Africa Platelet Rich Plasma Market Forecasts and Analysis - By Type
10.4.4 Middle East and Africa Platelet Rich Plasma Market Forecasts and Analysis - By Origin
10.4.5 Middle East and Africa Platelet Rich Plasma Market Forecasts and Analysis - By Application
10.4.6 Middle East and Africa Platelet Rich Plasma Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Platelet Rich Plasma Market
10.4.6.1.1 South Africa Platelet Rich Plasma Market by Type
10.4.6.1.2 South Africa Platelet Rich Plasma Market by Origin
10.4.6.1.3 South Africa Platelet Rich Plasma Market by Application
10.4.6.2 Saudi Arabia Platelet Rich Plasma Market
10.4.6.2.1 Saudi Arabia Platelet Rich Plasma Market by Type
10.4.6.2.2 Saudi Arabia Platelet Rich Plasma Market by Origin
10.4.6.2.3 Saudi Arabia Platelet Rich Plasma Market by Application
10.4.6.3 U.A.E Platelet Rich Plasma Market
10.4.6.3.1 U.A.E Platelet Rich Plasma Market by Type
10.4.6.3.2 U.A.E Platelet Rich Plasma Market by Origin
10.4.6.3.3 U.A.E Platelet Rich Plasma Market by Application
10.4.6.4 Rest of Middle East and Africa Platelet Rich Plasma Market
10.4.6.4.1 Rest of Middle East and Africa Platelet Rich Plasma Market by Type
10.4.6.4.2 Rest of Middle East and Africa Platelet Rich Plasma Market by Origin
10.4.6.4.3 Rest of Middle East and Africa Platelet Rich Plasma Market by Application
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Platelet Rich Plasma Market Overview
10.5.2 South and Central America Platelet Rich Plasma Market Forecasts and Analysis
10.5.3 South and Central America Platelet Rich Plasma Market Forecasts and Analysis - By Type
10.5.4 South and Central America Platelet Rich Plasma Market Forecasts and Analysis - By Origin
10.5.5 South and Central America Platelet Rich Plasma Market Forecasts and Analysis - By Application
10.5.6 South and Central America Platelet Rich Plasma Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Platelet Rich Plasma Market
10.5.6.1.1 Brazil Platelet Rich Plasma Market by Type
10.5.6.1.2 Brazil Platelet Rich Plasma Market by Origin
10.5.6.1.3 Brazil Platelet Rich Plasma Market by Application
10.5.6.2 Argentina Platelet Rich Plasma Market
10.5.6.2.1 Argentina Platelet Rich Plasma Market by Type
10.5.6.2.2 Argentina Platelet Rich Plasma Market by Origin
10.5.6.2.3 Argentina Platelet Rich Plasma Market by Application
10.5.6.3 Rest of South and Central America Platelet Rich Plasma Market
10.5.6.3.1 Rest of South and Central America Platelet Rich Plasma Market by Type
10.5.6.3.2 Rest of South and Central America Platelet Rich Plasma Market by Origin
10.5.6.3.3 Rest of South and Central America Platelet Rich Plasma Market by Application
11. IMPACT OF COVID-19 PANDEMIC ON GLOBAL PLATELET RICH PLASMA MARKET
11.1 North America
11.2 Europe
11.3 Asia-Pacific
11.4 Middle East and Africa
11.5 South and Central America
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. PLATELET RICH PLASMA MARKET, KEY COMPANY PROFILES
13.1. T-BIOTECHNOLOGY
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. ARTHREX, INC.
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. TERUMO BCT, INC.
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. EMCYTE CORPORATION
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. DEPUY SYNTHES
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. ZIMMER BIOMET
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. STRYKER
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. GLOFINN OY
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. DR. PRP AMERICA
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. CSL LIMITED
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
The List of Companies

1. T-BIOTECHNOLOGY
2. ARTHREX, INC.
3. TERUMO BCT, INC
4. EMCYTE CORPORATION
5. DEPUY SYNTHES
6. ZIMMER BIOMET
7. STRYKER
8. GLOFINN OY
9. DR. PRP AMERICA
10. CSL LIMITED
11. Apex Biologix
12. Juventix
13. Celling Biosciences
TIPRE00020948
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking